Geographic evidence hub
Published infectious-disease research classified with a high-confidence geographic relationship to Burkina Faso.
Evidence stream
10 publications
eLife
Why it matters nowThe findings indicate that subnational variation in net use after access may be relevant when considering malaria-control deployment strategies. The abstract describes a framework for using routinely collected data to support subnational programme tailoring.
PLOS Neglected Tropical Diseases
Why it matters nowRegional incidence estimates and strain distributions offer foundational parameters for evaluating pediatric immunization strategies and directing sanitation resource allocation.
Vaccine
Why it matters nowThe modeling results suggest that integrating adult demographics into future immunization campaigns could optimize resource allocation and disease reduction in highly affected regions. Policymakers might consider these economic parameters when planning next-generation preventive tools against this parasitic infection.
Journal of Infection
Why it matters nowThe findings support a simplified risk-stratified approach to initiating extended infant postnatal prophylaxis, potentially enabling more targeted and resource-efficient prevention of mother-to-child HIV transmission during breastfeeding.
BMC Infectious Diseases
Why it matters nowThe study describes pathogen distribution in childhood diarrhea in a low-income setting and reports that multiplex PCR testing supported broad pathogen detection in this population.
BMJ Global Health
Why it matters nowTwenty of thirty countries applying for vaccine support received financial approval from the Global Alliance for Vaccines and Immunization as of March 2024, demonstrating widespread interest. However, limited RTS,S/AS01 availability prevents some approved countries from receiving required doses, raising vaccine equity concerns.
New England Journal of Medicine
Why it matters nowThe trial addresses whether an added drug strategy could improve child outcomes during seasonal malaria chemoprevention in two African countries. The primary endpoint was serious illness or death, making the question relevant to child health and malaria-control programs.
Vaccine
Why it matters nowThe findings document the real-world impact of rotavirus vaccine in one of the first African countries to introduce RV5 nationally, demonstrating reductions in rotavirus-associated hospitalizations and supporting vaccine policy in similar settings.
Eurosurveillance
Why it matters nowThe study provides evidence on MERS-CoV circulation in African dromedary camel populations and identifies risk factors relevant to zoonotic transmission pathways from camels to humans.
Vaccine
Why it matters nowThe authors emphasize that findings support improved strategies to reduce missed vaccination opportunities and achieve high nationwide measles vaccination coverage to prevent large outbreaks and advance measles mortality reduction.
